Literature DB >> 7681692

The epitope for the inhibitory antibody M7-PB-E9 contains Ser-646 and Asp-652 of the sheep Na+,K(+)-ATPase alpha-subunit.

A Abbott1, W J Ball.   

Abstract

The binding of monoclonal antibody M7-PB-E9 to the alpha-subunit of Na+,K(+)-ATPase partially inhibits enzyme activity (35%) in competition with ATP, while in the presence of magnesium it stimulates the rate of ouabain binding severalfold [Ball, W. J. (1984) Biochemistry 23, 2275-2281]. These effects have been shown to result from an antibody-induced shifting of the enzyme's E1 <==> E2 conformational equilibrium to the right that affects all enzyme-ligand interactions except that with Mg2+ [Abbott, A.J., & Ball, W.J. (1992) Biochemistry 31, 11236-11243]. In order to identify the location of the M7-PB-E9 epitope, proteolytic fragments of the lamb kidney enzyme were generated and the immunoreactive alpha fragments were identified by Western blot analyses. These studies revealed a 47-kDa tryptic fragment, which bound both M7-PB-E9 and a -COOH terminus specific antisera and NH2-terminal sequencing showed to originate at Ala-590. Digestion with Staphylococcus aureus V8 protease produced a 36-kDa -COOH-terminus fragment which originated at Gly-697 and did not contain the antibody epitope. Thus the intracellular sequence region Ala-590 to Gly-697 was shown to contain the antibody epitope. When M7-PB-E9's ability to recognize the alpha subunits from various species and tissues was determined and correlated with available sequencing data, only Ser-646 was present in the highly reactive lamb, pig, and avian kidney alpha 1 proteins and altered (Asn) in the poorly recognized Xenopus and rat kidney and Torpedo electroplax organ enzymes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681692     DOI: 10.1021/bi00064a040

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility.

Authors:  S A Rajasekaran; L G Palmer; K Quan; J F Harper; W J Ball; N H Bander; A Peralta Soler; A K Rajasekaran
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

2.  Na,K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells.

Authors:  Sigrid A Rajasekaran; Jegan Gopal; Dianna Willis; Cromwell Espineda; Jeffery L Twiss; Ayyappan K Rajasekaran
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

3.  Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility.

Authors:  Sonali P Barwe; Gopalakrishnapillai Anilkumar; Sun Y Moon; Yi Zheng; Julian P Whitelegge; Sigrid A Rajasekaran; Ayyappan K Rajasekaran
Journal:  Mol Biol Cell       Date:  2004-12-22       Impact factor: 4.138

4.  Identification of the amino acids comprising a surface-exposed epitope within the nucleotide-binding domain of the Na+,K(+)-ATPase using a random peptide library.

Authors:  B Malik; G A Jamieson; W J Ball
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

5.  Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells.

Authors:  Sonali P Barwe; Anna Skay; Ryan McSpadden; Thu P Huynh; Sigrid A Langhans; Landon J Inge; Ayyappan K Rajasekaran
Journal:  J Cell Sci       Date:  2012-10-17       Impact factor: 5.285

6.  Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma.

Authors:  Cromwell E Espineda; Jay H Chang; Jeffery Twiss; Sigrid A Rajasekaran; Ayyappan K Rajasekaran
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

7.  Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression.

Authors:  Thu P Huynh; Sonali P Barwe; Seung J Lee; Ryan McSpadden; Omar E Franco; Simon W Hayward; Robert Damoiseaux; Stephen S Grubbs; Nicholas J Petrelli; Ayyappan K Rajasekaran
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.